Connect your AI

Versigent VGNT Unamortized Discount and Issuance Costs

Unamortized Discount and Issuance Costs at other companies

Warrior Met CoalHCC

$3.85M+92.1%

Blue Owl CapitalOWL

$10.23M+11.8%

Cohen & SteersCNS

$400K—

Tarsus Pharmaceuticals, Inc.TARS

$3.52M0.0%

FS KKR Capital Corp.FSK

$30M+15.4%

LPL Financial HoldingsLPLA

$10.4M—

Other financials

Income statement

Revenue$2.2B+9.3%

Gross profit$244.0M-2.0%

Operating income$74.0M-39.8%

Net income$78.0M-17.9%

Balance sheet

Cash & equivalents$282.0M—

Total debt$2.4B—

Total equity-$48.0M-103%

Total assets$4.9B—

Cash flow

Operating cash flow$36.0M-10.0%

CapEx$66.0M+78.4%

Free cash flow-$30.0M-1,100%

Valuation

Market cap$3.03B—

Returns & leverage

Debt / equity0.2×—

Current ratio1.4×—

Where this comes from

Reported directly by Versigent in its filing.

Tagged under the XBRL concept us-gaap:DeferredFinanceCostsGross.

The official record: Versigent ’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Versigent 's unamortized discount and issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Versigent 's unamortized discount and issuance costs?: Versigent (VGNT) reported unamortized discount and issuance costs of $9M in Q1 2026.